Strong leadership,
inspired by great science and a sense of mission

Dr. Levy serves as Chief Division of Critical Care, Pulmonary, and Sleep Medicine, Department of Medicine, The Warren Alpert Medical School of Brown University, where he is Professor of Medicine.

He is also Medical Director of the Medical Intensive Care Unit at Rhode Island Hospital, Providence, Rhode Island.  Dr. Levy is a founding member (2002) and a member of the Executive Committee of the Surviving Sepsis Campaign, a global initiative to improve the care of patients with severe sepsis.

He is the lead investigator for Phase III of the campaign, the goal of which is to facilitate adoption of evidence-based guidelines for sepsis management into clinical practice and reduce mortality in severe sepsis by 25% by 2009.

Dr. Levy is Past-President of the Society of Critical Care Medicine (2009).  He has authored over 130 peer-reviewed articles and book chapters. He is the co-director of the Ocean State Clinical Coordinating Center, which manages large, international, multi-center clinical trials in sepsis.

Dr. Deutschman is a graduate of Trinity College (BS), Northwestern University (MS) and New York Medical College (MD). After flirtations with surgery and neurosurgery he completed training in surgical critical care (Univ of Minnesota) and Anaesthesiology (Johns Hopkins). He was on the faculty at Johns Hopkins (1988-1993) and Penn (1993-2014) as a specialist in Critical (Intensive) Care Medicine. As a member of Penn’s Department of Anaesthesiology and Critical Care, he directed the Fellowship in Critical Care Medicine, the NIH-funded Research Fellowship (T32) and the Stavropoulos Sepsis Research Program. He joined Northwell Health as vice chairman of research for the Department of Pediatrics in 2014.

Dr. Deutschman has served as president of the Society of Critical Care Medicine in 2012, and the American Society of Critical Care Anaesthesiologists from 2002 to 2004. He has been a permanent member of the NIH Surgery, Anaesthesia and Trauma Study Section. He is scientific editor of the journal, Critical Care Medicine, and serves on the editorial boards of a number of other journals. He has been the recipient of a number of awards and honors including the Lifetime Achievement Award from the Society of Critical Care Anaesthesiologists.

Dr Deutschman’s research focuses on sepsis, a common, life-threatening disorder that arises when the body’s response to infection injures its’ own tissues and organs, a topic on which he is achieved international recognition. He is one of the co-authors of the most recent version of Surviving Sepsis Campaign Guidelines and is currently co-chair of an international task force to re-examine and refine the definitions of sepsis.

Dr. Deutschman has co-authored over 100 peer-reviewed publications and over 80 book chapters and editorials. He is the co-editor of the textbook Evidence-Based Practice of Critical Care.

Dr. Mervyn Singer is Professor of Intensive Care Medicine at University College London. Dr Singer co-chaired the Sepsis-3 Definitions International Task Force that redefined sepsis in 2016, was founding Editor-in-Chief of Intensive Care Medicine Experimental and an ex-Chair of the International Sepsis Forum. He is currently the Sepsis Topic Advisor to NICE and on the Steering Committee for the update of the SOFA score.

Dr. François is specialist in Intensive Care medicine at the University Hospital of Limoges, France. As of 2008, Dr. François is the head of the Limoges Clinical Investigation Center (Inserm CIC-P 1435), and his main expertise is Infectious Diseases in critically ill patients. He has been national and international coordinator for numerous emergency trials especially in Sepsis, VAP and VAP prevention, and has participated in several advisory boards for Sepsis and VAP multinational trials, independent Clinical Evaluation Committees and Adjudication Committees. He created the CRICS network dedicated to clinical research in Sepsis trials in 2007 and has been the coordinator of the French F-CRIN certified CRICS-TRIGGERSEP research network which integrates all research activities in Sepsis from basic science to clinical trials. Since 2012, he is co-coordinating the COMBACTE-Net consortium within the IMI framework as academics partners and has been leading trials in collaboration with pharmaceutical companies developing new therapeutic pre-emptive approach of VAP with monoclonal antibodies against Staphylococcus aureus and Pseudomonas aeruginosa. Since 2021, he is a member of the coordinating committee of Ecraid, the first academic infrastructure in Europe that offers a single point of access to a pan-European clinical research network for infectious diseases. Since 2021, he is co-coordinating PROMISE which is a French meta-network dedicated to antimicrobial resistance within a one-health approach.

Prof. Dr. Tobias Winkler is orthopedic and trauma surgeon at the Center for Muskuloskeletal Surgery (CMSC) at the Charité Berlin. His research work is performed at the Berlin Institute of Health Center for Regenerative Therapies (BCRT) and the Julius Wolff Institute (JWI) of the Berlin Institute of Health @Charité, where he holds a Professorship for Regenerative Orthopedics and Traumatology. In 2009 Prof. Winkler received the Innovation Award of the German Society for Trauma Surgery, in 2018 the Award for Applied Science of the German Society of Arthroplasty. Prof. Winkler is coordinator of two international research consortia funded by the European Commission programs Horizon 2020 and Horizon Europe on allogeneic cell therapies for skeletal muscle injury and osteoarthritis. He is head of a research team, which main focus is the translation of advanced therapies for musculoskeletal indications. His research work in the field encompasses cell therapies with adult mesenchymal and blood cells for bone, tendon and muscle regeneration and the development of biomaterials for bone regeneration. Prof. Winkler is also co-founder and executive board member of the Advanced Therapies in Orthopedics Foundation – ATiO.

Professor Hunter serves as the Florance and Cope Chair of Rheumatology, Professor of Medicine, NHMRC Leadership Investigator Fellow at the Sydney Musculoskeletal Health, Kolling Institute, University of Sydney and Rheumatology Department, Royal North Shore Hospital. Professor Hunter is a rheumatologist clinician-researcher whose primary research focus is clinical and translational research in osteoarthritis. He is ranked as the leading expert in the world on osteoarthritis on expertscape.com, is the section editor for UpToDate osteoarthritis, the Editor in Chief for Osteoarthritis and Cartilage, and has over 600 publications in peer-reviewed journals. He is co-Director of Sydney Musculoskeletal Health and leads the osteoarthritis team at the Kolling Institute who are dedicated to improving our understanding of osteoarthritis and the quality of life for those who suffer from this prevalent disabling disease.

Ali Mobasheri is Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology within the Faculty of Medicine at the University of Oulu in Finland. He also holds the position of Chief Researcher and International Adviser in the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. He is the Immediate Past President of the Osteoarthritis Research Society International (OARSI) and serves on the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). In addition, he serves as “Collaborateur Scientifique de l’Université de Liège” and Senior Strategic Advisor to the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Aging, Université de Liège, Liège, Belgium. He is a member of the International Cartilage Regeneration & Joint Preservation Society (ICRS) and serves on the Regulatory and Industry Liaison Committee of ICRS.